Cn Bio Innovations
CN Bio develops human organ-on-a-chip platforms for the testing and development of therapeutics for serious human diseases.
Total raised
€28M
€27,849,028
Funding rounds
2
Investors
2
distinct backers
Active since
2020-02
latest 2024-04
Funding by year
EUR raised per yearSignals
High confidenceRaise-next likelihood59
base rate 48% for Series B
- ▲ In typical raise window
- ▲ Up-round momentum
- ▼ Low backer re-investment
Exit likelihood13
base rate 12% (2+ rounds)
- ▲ 17y since founding
Timing: in window vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2024-04-23 | Series B | €20M | Bayland Capital,CN Innovations Holdings | View deal → |
| 2020-02-03 | Other | €8.1M | — | View deal → |